- Home
- HRZN vs BIOA Comparison
HRZN vs BIOA Comparison
Compare HRZN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRZN | BIOA |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.5M | 255.6M |
| IPO Year | 2010 | 2024 |
Fundamental Metrics
Financial Performance| Metric | HRZN | BIOA |
|---|---|---|
| Price | $3.92 | $5.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $5.08 | ★ $32.56 |
| AVG Volume (30 Days) | 423.8K | ★ 790.2K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | ★ 18.27% | N/A |
| EPS Growth | 62.50 | ★ 66.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,995,000.00 |
| Revenue This Year | $4.55 | N/A |
| Revenue Next Year | $14.68 | $97.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $4.81 |
| 52 Week High | $6.85 | $25.96 |
Technical Indicators
Market Signals| Indicator | HRZN | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 23.61 | 34.04 |
| Support Level | $3.85 | $4.81 |
| Resistance Level | $4.75 | $8.53 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 6.76 | 30.12 |
Price Performance
Historical ComparisonAbout HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.